Ignite Creation Date:
2024-05-06 @ 1:10 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03959891
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2019-05-15
Brief Title:
AKT Inhibitor Ipatasertib With Endocrine and CDK 46 Inhibitor for Patients With Metastatic Breast Cancer TAKTIC
Sponsor:
Organization:
Massachusetts General Hospital